Proteinase-3-anti-neutrophil cytoplasmic antibodies (PR3-ANCAs) predict relapses in ANCA-associated vasculitis patients after rituximab

Author(s):: Dam, L.S. van (0000-0001-6373-7673); Dirikgil, E.; Bredewold, E.W.; Ray, A.; Bakker, J.A. (0000-0002-2918-7361); Kooten, C. van (0000-0002-6257-0899); Rabelink, T.J.; Teng, Y.K.O. (0000-0001-9920-2195)

Published: 2020
Publication type: Article / Letter to editor

Date issued: 2020-06-30
Language: English
Publisher: Oxford University Press
Is part of: Nephrology Dialysis Transplantation (2020), Vol. 36, no. 8, p. 1408-1417
hdl: 1887/3276094
doi: 10.1093/ndt/gfaa066
URL: https://academic.oup.com/ndt/article/36/8/1408/5864952